comparemela.com
  1. Home
  2. Live Updates
  3. Exchange Regulation - Breaking News

Page 5 - Exchange Regulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024 - adhoc - Börsennachrichten

Spexis AG Key word Miscellaneous Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31 2024 30Apr2024 2030

Switzerland generalMartin jakobovicStephan feldhausExchange regulationListing rulesChief financial

Adhoc: Spexis AG: Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024

Adhoc: Spexis AG: Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalZwei rohstoff chancenStephan feldhausMartin jakobovicExperte carsten storkExchange regulationNews serviceSwiss exchangeListing rulesChief financial

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024 - adhoc - Börsennachrichten

Spexis AG Key word Miscellaneous Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31 2024 30Apr2024 2030

Switzerland generalMartin jakobovicStephan feldhausExchange regulationListing rulesChief financial

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual repo

Spexis AG / Key word(s): Miscellaneous30-Apr-2024 / 20:30 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, April 30, 2024Spexis receives approval of an extension of t.

Switzerland generalMartin jakobovicStephan feldhausExchange regulationListing rulesChief financial

Cosmo Pharmaceuticals N : has received approval of an extension in respect of the publication and the filing of its annual report 2023

Dublin, Ireland - 29 April 2024: Cosmo Pharmaceuticals N.V. today announced that the company has been granted extension until 31 May 2024 to publish its 2023 annual report and to file such.

Hazel winchesterExchange regulationCosmo pharmaceuticalsListing rules

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.